tiprankstipranks
Tevogen Bio Holdings (TVGN)
NASDAQ:TVGN
US Market
TVGN
Tevogen Bio Holdings
RESEARCH TOOLSreports

Tevogen Bio Holdings (TVGN) Income Statement

325 Followers

Tevogen Bio Holdings Income Statement

Last quarter (Q4 2025), Tevogen Bio Holdings's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Tevogen Bio Holdings's net income was $-4.68M. See Tevogen Bio Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -403.58K$ -378.36K$ 0.00$ 0.00
Operating Expenses
$ 26.14M$ 53.16M$ 8.46M$ 953.08K$ 4.62M
Depreciation and Amortization
$ 0.00$ 403.58K$ 378.36K$ 0.00$ 9.38K
EBITDA
$ -26.14M$ -13.14M$ -58.89M$ 4.41M$ -14.99M
Operating Income
$ -26.14M$ -53.56M$ -8.84M$ -953.08K$ -4.62M
Other Income/Expenses
$ -134.92K$ 39.84M$ -51.63M$ 5.36M$ -10.98M
Pretax Income
$ -26.28M$ -13.73M$ -60.48M$ 4.41M$ -15.60M
Net Income
$ -26.28M$ -10.11M$ -60.48M$ 4.41M$ -15.60M
Per Share Metrics
Basic EPS
$ -8.08$ -4.68$ -0.02$ 1.83$ -16.50
Diluted EPS
$ -8.08$ -4.68$ -0.02$ 1.83$ -16.50
Weighted Average Shares Outstanding
 3.32M 2.93M 3.31M 2.40M 958.67K
Weighted Average Shares Outstanding (Diluted)
 3.32M 2.93M 3.31M 2.40M 958.67K
Currency in USD

Tevogen Bio Holdings Earnings and Revenue History